Back

Risk factors for heart failure after doxorubicin chemotherapy for breast- or colorectal cancer

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Cardiomyopathies: understanding the enemy Cardiotoxicity of drugs ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Gyorgy Fogarassy

Balatonfured State Cardiology Hospital, Balatonfured (Hungary)

8 More presentations in this session

Presentation thumbnail
First Australian registry of patients with wild type cardiac amyloidosis (ATTRwt): Queensland experience.
Doctor M. Burrage (Brisbane, AU)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics of ST-elevation and non-ST-elevation types in patients with takotsubo syndrome -a multicenter registry in eight-university hospitals in East Japan
Assistant Professor M. Yoshizawa (Morioka, JP)
Abstract Slides Video
Presentation thumbnail
Myocardial bridging and left ventricular thrombus formation in patients with takotsubo cardiomyopathy
Doctor B. Schneider (Luebeck, DE)
Abstract
Presentation thumbnail
Predictors of heart failure hospitalizations in hypertrophic cardiomyopathy
Doctor A. Cecconi (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Non-linear dynamics of heart rate variability independently predicts all-cause mortality of patients with Sarcoidosis
Doctor E. Gialafos (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiomyopathies: understanding the enemy

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources